Citius Pharmaceuticals
CTXR
$0.70
Share price
-0.28%
Change (1 day)
-43.60%
Change (1 year)
Categories
Earnings for Citius Pharmaceuticals (CTXR)
Earnings in 2023 (TTM): -$37.61 M
According to Citius Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$37.61 M. In 2022 the company made an earning of -$27.29 M a decrease over its 2021 earnings that were of -$24.14 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Citius Pharmaceuticals from 2011 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$37.61 M | 37.8% |
| 2022 | -$27.29 M | 13.08% |
| 2021 | -$24.14 M | 12.91% |
| 2020 | -$21.38 M | 33.5% |
| 2019 | -$16.01 M | 21.61% |
| 2018 | -$13.17 M | 14.93% |
| 2017 | -$11.46 M | 23.83% |
| 2016 | -$9.26 M | 180.39% |
| 2015 | -$3.3 M | |
| 2013 | -$0.57 M | 2605.74% |
| 2012 | -$0.03 M | 4.81% |
| 2011 | -$0.02 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | 194.59% | 🇺🇸 USA |